Health and Healthcare

Pfizer : PFE

All Pfizer Articles

1482 Articles

Chris Lange | Aug 10, 2017 at 8:40 AM EDT

Short Sellers Hike Bets in Major Pharma

The July 31 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Aug 5, 2017 at 9:10 AM EDT

Why Apple Isn’t the Only Dow Stock That Analysts Are Thrilled About

A few analysts released reports this past week calling for these three Dow stocks to rise even higher (at least…

Paul Ausick | Aug 3, 2017 at 4:01 PM EDT

Pfizer, UnitedHealth Help Buoy DJIA Thursday

The DJIA was headed for a nearly flat close Thursday, with Pfizer and UnitedHealth offsetting share price declines at Apple…

Chris Lange | Aug 2, 2017 at 1:35 PM EDT

Why Analysts Are Growing More Bullish on 3 Dow Stocks That Aren’t Apple

A few analysts released reports Wednesday calling for three Dow stocks to rise even higher. It seems at this rate…

Jon C. Ogg | Aug 2, 2017 at 9:10 AM EDT

Top Analyst Upgrades and Downgrades: Apple, Caterpillar, Pfizer, Royal Caribbean, Shopify, Under Armour, Walmart and More

The top analyst upgrades, downgrades and other research calls from Wednesday include Apple, Caterpillar, Pfizer, Royal Caribbean, Shopify, Under Armour…

Paul Ausick | Aug 1, 2017 at 7:55 AM EDT

Why Pfizer Earnings Aren’t Exciting Investors

Pharmaceuticals maker Pfizer reported second-quarter earnings before markets opened Tuesday, beating profit estimates by a penny a share, but coming…

Chris Lange | Jul 30, 2017 at 10:25 AM EDT

Apple, Tesla and More Companies Reporting This Week

24/7 Wall St. has put together a quick preview Apple, Pfizer, Tesla and some of the other top companies reporting…

Chris Lange | Jul 26, 2017 at 8:55 AM EDT

Major Pharma Short Interest Takes a Big Step Back

The July 14 short interest data have been compared with the previous figures, and short interest in most of these…

Lee Jackson | Jul 24, 2017 at 8:25 AM EDT

The Stock Market Is Very Expensive: 5 Safe Blue Chips to Buy Now

These five top stocks rated Buy all pay good dividends and offer a degree of safety in what is clearly…

Chris Lange | Jul 21, 2017 at 8:37 AM EDT

Why Credit Suisse Prefers Johnson & Johnson Over Pfizer

Major pharmaceutical companies have posted a relatively positive year so far. Currently, Johnson & Johnson (NYSE: JNJ) is leading the…

Jon C. Ogg | Jul 20, 2017 at 9:24 AM EDT

Top Analyst Upgrades and Downgrades: BHP Billiton, HP, Kinder Morgan, Marathon Petroleum, Nike, Pfizer, Rite Aid, Tesla and More

Stocks were indicated marginally higher on Thursday after the European Central Bank statement remained quite dovish. The major equity indexes…

Paul Ausick | Jul 17, 2017 at 4:01 PM EDT

IBM, JPMorgan Weigh on DJIA Monday

IBM, JPMorgan, Pfizer, and Merck were the poorest performing stocks among the Dow 30 on Monday.

Chris Lange | Jul 13, 2017 at 9:20 AM EDT

Major Pharma Short Sellers Become More Selective

The June 30 short interest data have been compared with the previous figures, and short interest moves in these selected…

Chris Lange | Jul 7, 2017 at 1:00 PM EDT

FDA Issues an Approval Not Seen in Almost 20 Years

In an incredible move on Friday, the FDA approved Endari for the treatment of patients age five and older with…

Chris Lange | Jun 27, 2017 at 8:45 AM EDT

Short Sellers Run for Cover From Major Pharma

The June 15 short interest data have been compared with the previous figures, and short interest in most of these…

1 … 39 40 41 42 43 … 99

Pfizer : PFE

All Pfizer Articles

Short Sellers Hike Bets in Major Pharma

Why Apple Isn’t the Only Dow Stock That Analysts Are Thrilled About

Pfizer, UnitedHealth Help Buoy DJIA Thursday

Why Analysts Are Growing More Bullish on 3 Dow Stocks That Aren’t Apple

Top Analyst Upgrades and Downgrades: Apple, Caterpillar, Pfizer, Royal Caribbean, Shopify, Under Armour, Walmart and More

Why Pfizer Earnings Aren’t Exciting Investors

Apple, Tesla and More Companies Reporting This Week

Major Pharma Short Interest Takes a Big Step Back

The Stock Market Is Very Expensive: 5 Safe Blue Chips to Buy Now

Why Credit Suisse Prefers Johnson & Johnson Over Pfizer

Top Analyst Upgrades and Downgrades: BHP Billiton, HP, Kinder Morgan, Marathon Petroleum, Nike, Pfizer, Rite Aid, Tesla and More

IBM, JPMorgan Weigh on DJIA Monday

Major Pharma Short Sellers Become More Selective

FDA Issues an Approval Not Seen in Almost 20 Years

Short Sellers Run for Cover From Major Pharma

If You Have $620,000 Saved at 67 and a $90,000 Pension Buyout Decision, Here Is the Lump Sum Math

Why a $2.1 Million 401(k) Holder Is Moving From California to Nevada Before His First RMD at 73

Most Income Investors Have Never Heard of These 3 ETFs Paying Over 10 Percent Monthly

If You Have $620,000 Saved at 67 and a $90,000 Pension Buyout Decision, Here Is the Lump Sum Math

Why a $2.1 Million 401(k) Holder Is Moving From California to Nevada Before His First RMD at 73

If You Have $620,000 Saved at 67 and a $90,000 Pension Buyout Decision, Here Is the Lump Sum Math

Why a $2.1 Million 401(k) Holder Is Moving From California to Nevada Before His First RMD at 73

Pfizer : PFE

All Pfizer Articles

Short Sellers Hike Bets in Major Pharma

Why Apple Isn’t the Only Dow Stock That Analysts Are Thrilled About

Pfizer, UnitedHealth Help Buoy DJIA Thursday

Why Analysts Are Growing More Bullish on 3 Dow Stocks That Aren’t Apple

Top Analyst Upgrades and Downgrades: Apple, Caterpillar, Pfizer, Royal Caribbean, Shopify, Under Armour, Walmart and More

Why Pfizer Earnings Aren’t Exciting Investors

Apple, Tesla and More Companies Reporting This Week

Major Pharma Short Interest Takes a Big Step Back

The Stock Market Is Very Expensive: 5 Safe Blue Chips to Buy Now

Why Credit Suisse Prefers Johnson & Johnson Over Pfizer

Top Analyst Upgrades and Downgrades: BHP Billiton, HP, Kinder Morgan, Marathon Petroleum, Nike, Pfizer, Rite Aid, Tesla and More

IBM, JPMorgan Weigh on DJIA Monday

Major Pharma Short Sellers Become More Selective

FDA Issues an Approval Not Seen in Almost 20 Years

Short Sellers Run for Cover From Major Pharma

If You Have $620,000 Saved at 67 and a $90,000 Pension Buyout Decision, Here Is the Lump Sum Math

Why a $2.1 Million 401(k) Holder Is Moving From California to Nevada Before His First RMD at 73

Most Income Investors Have Never Heard of These 3 ETFs Paying Over 10 Percent Monthly

Featured Reads

If You Have $620,000 Saved at 67 and a $90,000 Pension Buyout Decision, Here Is the Lump Sum Math

Why a $2.1 Million 401(k) Holder Is Moving From California to Nevada Before His First RMD at 73